Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances

Bristol Myers Squibb • Princeton, NJ

3d • $326,660 - $395,829

About The Position

The Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances provides strategic leadership for Bristol Myers Squibb’s Oncology Medical Evidence Generation (MEG) portfolio across solid tumor and hematology. The role owns the three-year strategic MEG plan for Oncology, the largest MEG portfolio, representing approximately 60% of the overall Book of Work, and partners with worldwide Therapeutic Area leadership to set direction, priorities, and portfolio trade-offs.

The position establishes the strategic framework and provides executive oversight for Integrated Evidence Plans (IEPs) across Oncology assets and indications, aligning evidence generation with unmet medical needs and enterprise priorities. It holds accountability for the strategic direction, prioritization, governance, resourcing, and impact of the Oncology MEG Book of Work, which includes Medical Affairs-sponsored studies, clinical research collaborations, investigator-sponsored studies, and Real World Evidence studies.

As a senior matrix partner to global and international medical leadership, the Vice President guides Medical governance, sponsors MEG leadership forums, and represents the Oncology Book of Work to senior leaders and enterprise stakeholders. The role champions innovation, digital and AI tools, data analytics, and evidence-based portfolio decisions; oversees scientific rigor, quality, timeliness, and fiscal stewardship; and chairs review committees for protocols, amendments, and study budgets.

The role leads and develops a team of more than 25 professionals, including MEG Leads, Clinical Scientists, Clinical Trial Physicians, and project managers. It emphasizes building organizational capability and empowering leaders to deliver execution, rather than managing operational details day to day. The position also represents the enterprise in engagements with investigators, external stakeholders, and executive teams. It is HQ based and requires approximately 25% international and domestic travel.

Requirements

• Advanced scientific degree, such as Pharm.D., MD, or PhD.
• At least 15 years of experience.
• At least 5 years of clinical trial expertise, with a mix of development/clinical and medical experience and an emphasis on trial conduct and execution.
• Demonstrated experience operating at a strategic, portfolio-wide level.
• Proven ability to align diverse senior teams and influence executive stakeholders toward shared strategic success.
• Demonstrated ability to set strategic direction and drive initiatives that produce measurable enterprise-level impact and results.
• Strong track record of building and developing organizational talent and future leaders, with a focus on performance, engagement, and growth at scale.
• Ability to anticipate market dynamics and identify strategic opportunities to accelerate pipeline development across a major portfolio.
• Strong executive presence, excellent analytical skills, and ability to interpret and contextualize strategic evidence.
• Ability to influence effectively across senior cross-functional teams, including GDD, commercialization, regulatory, HEOR, and Access.
• HQ-based position with approximately 25% international and domestic travel.

Nice To Haves

• Formal specialization in areas associated with the current Oncology portfolio (solid tumor and/or hematology), and/or professional experience with assets in this space.

Responsibilities

• Own the three-year strategic MEG plan for Oncology across solid tumor and hematology, setting portfolio direction, priorities, and trade-offs in partnership with worldwide Therapeutic Area leadership.
• Set the strategic framework for and provide executive oversight of Integrated Evidence Plans for Oncology assets and indications, aligning plans with unmet medical needs and enterprise priorities.
• Hold accountability for the strategic direction, prioritization, governance, resourcing, and enterprise impact of the Oncology MEG Book of Work, including Medical Affairs-sponsored studies, clinical research collaborations, investigator-sponsored studies, and Real World Evidence studies.
• Partner with Global Therapeutic Area, Global Medical, and International Medical leadership teams as a senior matrix leader.
• Set direction for Medical governance through the TAG forum and provide executive sponsorship for MEG leads conducting EGWG meetings.
• Champion innovation and use digital and AI tools, data analytics, and business acumen to guide portfolio-level evidence generation and data-driven decisions.
• Provide senior scientific and strategic oversight of studies, ensuring rigor, timeliness, and quality while maintaining fiscal stewardship and a balanced portfolio budget.
• Chair review committees for final protocols, amendments, and budgets for studies within remit, making executive judgments on portfolio-level trade-offs.
• Serve as the senior subject matter expert and executive voice for the Oncology Book of Work, delivering strategic updates to senior leadership and enterprise stakeholders.
• Lead, develop, and set strategic direction for a team of more than 25 professionals, building organizational capability and empowering team leaders.
• Represent the enterprise in engagements with investigators, external stakeholders, and cross-functional executive teams, shaping scientific rationale and portfolio-level decisions about execution, budgets, and data readouts.
• Travel internationally and domestically approximately 25% of the time.

Benefits

• Comprehensive benefit plans, including wellbeing support, retirement and financial protection benefits, and medical, dental, vision, life, and disability insurance offerings.
• For eligible U.S.-based exempt employees, Flexible Time Off without a set accrual limit, subject to manager approval.
• 11 paid company holidays each year.
• For eligible non-exempt employees, RayzeBio employees, and employees located in Puerto Rico: 160 hours of paid vacation annually for new hires, subject to manager approval, 11 paid company holidays, and 3 optional holidays.
• Depending on eligibility, paid sick leave, up to two paid volunteer days per year, summer hours flexibility, and leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs.
• Eligible employees may receive an annual Global Shutdown between Christmas Day and New Year's Day.
• Potential eligibility for discretionary incentive cash and stock opportunities.

What This Job Offers

• Job Type: Full-time
• Career Level: Executive
• Education Level: Ph.D. or professional degree